Safety Assessment of the Pharmacotherapy Process at the Nurse and Midwife Level - An Observational Study

Ther Clin Risk Manag. 2020 Nov 4:16:1057-1065. doi: 10.2147/TCRM.S276901. eCollection 2020.

Abstract

Purpose: Pharmacological errors are among the most common in the healthcare system. This study aimed to determine the level of safety of the pharmacotherapy process at the stage performed by nurses and midwives by indicating the key risk factors affecting patients' safety.

Methods: A group of 1276 nurses and 136 midwives in Poland participated in the study. The survey was conducted in the period from May 2019 to August 2019. The original Nursing Risk in Pharmacotherapy (NURIPH) tool was used.

Results: The Cronbach alpha coefficient was 0.832. The low legibility of the medical orders (item 1) was indicated as the highest risk. A mean of 4.50 means that this factor's significance is assessed between "very significant" and "significant." The communication between physician, nurse and midwife, time pressure, and work organization were also rated high (Items 2, 3, and 4). The averages for these factors are higher than 4, so their evaluation is more than "significant.".

Conclusion: Nurses and midwives involved in the pharmacotherapy process are exposed to many ergonomic factors triggering risk. A huge problem is the lack of readability of medical orders, which may be a factor triggering a medical error.

Keywords: NURIPH tool; medication error; nurses and midwives; patient safety; pharmacotherapy; risk management.

Grants and funding

This study was conducted under a research project funded by the Ministry of Science and Higher Education of Poland as a statutory grant of the Wroclaw Medical University for maintaining research potential (no. SUB.E140.19.042).